These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29991543)

  • 21. [Drug-induced hepatitis in pulmonary tuberculosis patients].
    Koriakin VIa; Sokolova GB; Ziia AV; Zeliger LR; Glik MS
    Vrach Delo; 1984 May; (5):60-2. PubMed ID: 6741089
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of childhood tuberculosis: consensus statement of IAP Working Group.
    Amdekar YK
    Indian Pediatr; 1998 Dec; 35(12):1263-4. PubMed ID: 10216716
    [No Abstract]   [Full Text] [Related]  

  • 23. Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus.
    Ungo JR; Jones D; Ashkin D; Hollender ES; Bernstein D; Albanese AP; Pitchenik AE
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1871-6. PubMed ID: 9620920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Moxifloxacin induced encephalopathy in disseminated tuberculosis: A case report.
    Mittal GK; Reddy VASK; Akhtar SM; Kaur H
    Indian J Tuberc; 2020 Jul; 67(3):423-425. PubMed ID: 32825886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost effectiveness of decentralised care model for managing MDR-TB in India.
    John D; Chatterjee P; Murthy S; Bhat R; Musa BM
    Indian J Tuberc; 2018 Jul; 65(3):208-217. PubMed ID: 29933862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients.
    Teixeira RL; Morato RG; Cabello PH; Muniz LM; Moreira Ada S; Kritski AL; Mello FC; Suffys PN; Miranda AB; Santos AR
    Mem Inst Oswaldo Cruz; 2011 Sep; 106(6):716-24. PubMed ID: 22012226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of risk factors for antituberculosis treatment induced hepatotoxicity.
    Singla R; Sharma SK; Mohan A; Makharia G; Sreenivas V; Jha B; Kumar S; Sarda P; Singh S
    Indian J Med Res; 2010 Jul; 132():81-6. PubMed ID: 20693595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of an ofloxacin-based antitubercular regimen for the treatment of tuberculosis in patients with underlying chronic liver disease: a preliminary report.
    Saigal S; Agarwal SR; Nandeesh HP; Sarin SK
    J Gastroenterol Hepatol; 2001 Sep; 16(9):1028-32. PubMed ID: 11595068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventive use of hepatoprotectors yields limited efficacy on the liver toxicity of anti-tuberculosis agents in a large cohort of Chinese patients.
    Wu S; Xia Y; Lv X; Tang S; Yang Z; Zhang Y; Wang X; Hu D; Liu F; Yuan Y; Tu D; Sun F; Zhou L; Zhan S
    J Gastroenterol Hepatol; 2015 Mar; 30(3):540-5. PubMed ID: 25160904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of drug-induced hepatitis occurring in elderly and younger patients during anti-tuberculosis treatment with a regimen including pyrazinamide].
    Miyazawa N; Horita N; Tomaru K; Tsukahara T; Takahashi R; Sasaki M; Ishigatsubo Y
    Kekkaku; 2013 Mar; 88(3):297-300. PubMed ID: 23672170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pattern of adverse drug reactions experienced by tuberculosis patients in a tertiary care teaching hospital in Western Nepal.
    P V K; Palaian S; Ojha P; P R S
    Pak J Pharm Sci; 2008 Jan; 21(1):51-6. PubMed ID: 18166520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Liver damage caused by the continued use of chemotherapy of pulmonary tuberculosis].
    Yamazaki M; Endo K; Noguchi T; Nakano M
    Iryo; 1966 Apr; 20(4):347-53. PubMed ID: 5974193
    [No Abstract]   [Full Text] [Related]  

  • 33. Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB).
    Liu Y; Matsumoto M; Ishida H; Ohguro K; Yoshitake M; Gupta R; Geiter L; Hafkin J
    Tuberculosis (Edinb); 2018 Jul; 111():20-30. PubMed ID: 30029909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fulminant hepatitis in the course of antitubercular treatment (apropos of 2 cases)].
    Mbaye PS; Talarmin F; Sane M; Eladari D; Klotz F
    Dakar Med; 1995; 40(2):129-31. PubMed ID: 9827070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective clinical study of isoniazid-rifampicin-pyrazinamide-induced liver injury in an area endemic for hepatitis B.
    Hwang SJ; Wu JC; Lee CN; Yen FS; Lu CL; Lin TP; Lee SD
    J Gastroenterol Hepatol; 1997 Jan; 12(1):87-91. PubMed ID: 9076631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tuberculosis treatment. Risk, benefit and perspective.
    Glassroth J
    Chest; 1991 Feb; 99(2):266-7. PubMed ID: 1989779
    [No Abstract]   [Full Text] [Related]  

  • 38. Are we justified in treating for multidrug-resistant tuberculosis based on positive follow-up smear results?
    Kumar RS; Kumar AM; Claassens M; Banurekha VV; Sekar G; Venkatesan P; Swaminathan S
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):449-53. PubMed ID: 24670701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-TB drug concentrations and drug-associated toxicities among TB/HIV-coinfected patients.
    Sekaggya-Wiltshire C; von Braun A; Scherrer AU; Manabe YC; Buzibye A; Muller D; Ledergerber B; Gutteck U; Corti N; Kambugu A; Byakika-Kibwika P; Lamorde M; Castelnuovo B; Fehr J; Kamya MR
    J Antimicrob Chemother; 2017 Apr; 72(4):1172-1177. PubMed ID: 28108678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of Drug-Responsive T-Lymphocytes in a Case of Fatal Antituberculosis Drug-Related Liver Injury.
    Usui T; Whitaker P; Meng X; Watson J; Antoine DJ; French NS; Park BK; Naisbitt DJ
    Chem Res Toxicol; 2016 Nov; 29(11):1793-1795. PubMed ID: 27933861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.